Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma

The incidence of irAEs in this cohort is lower than reported in controlled trials, withouut impact on survival outcomes. Education and early recognition are crucial to ensure that these events are identified and addressed.

Authors

Institutions

Publication Details

Journal
Oncotarget
Published
2025-05-19
DOI
https://doi.org/10.18632/oncotarget.28721
Citations
1
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
1.32
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma

Adriana Varón, Alexandre de Araújo, Jaime Poníachik, Juan Ignacio Marín et al.
1 citations
Oncotarget
Hepatocellular Carcinoma Treatment and Prognosis
1.32
article

Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma

Adriana Varón, Alexandre de Araújo, Jaime Poníachik, Juan Ignacio Marín, Ezequiel Demirdjian, Leonardo Gomes da Fonseca, J. Flórez, Fernando Bessone, Manuel Mendizábal, Federico Piñero, Ezequiel Ridruejo, M.D. Villa, Sebastián Marciano, Margarita Anders, Pablo Caballini, Daniela Perez, Carla Bermúdez, Oscar Beltrán, Jorge Rodríguez, Federico Orozco
article en
1 citations

Abstract

The incidence of irAEs in this cohort is lower than reported in controlled trials, withouut impact on survival outcomes. Education and early recognition are crucial to ensure that these events are identified and addressed.

OncotargetVol. 16(1)
University of Mendoza (AR), Universidade Federal do Rio Grande do Sul (BR), Hospital Italiano de Buenos Aires (AR), Instituto do Câncer do Estado de São Paulo (BR), Hospital de Clínicas de Porto Alegre (BR), Hospital Universitario Austral (AR), Hospital Pablo Tobon Uribe (CO), Hospital Provincial de Rosario (AR), Hospital Clínico de la Universidad de Chile (CL), Fundación Santa Fe de Bogotá (CO), Institute of Cardiology (CO), Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (AR), Hospital Alemán (AR)
Openalex Percentile: Top 21%
Hepatocellular Carcinoma Treatment and Prognosis
1.32
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.